Abstract
OPINION article Front. Neurol., 12 January 2015Sec. Neurodegeneration https://doi.org/10.3389/fneur.2014.00288
Highlights
Of the several thousand research studies published in the field of Alzheimer’s disease (AD), only a tiny fraction are devoted to sex differences
Cognitive tests commonly used to screen for AD or measure progression in routine practice (e.g., MMSE) are known to show gender differences – suggesting that factors such as detection bias, cognitive reserve/education, or sociocultural effects could potentially contribute to gender differences in AD rates
Holland et al [11] studied 668 subjects and examined gender effects on brain atrophy and cognitive decline over a 3-year-period in a linear mixed effects model controlling for age, education, ApoE4, and baseline cognition
Summary
Of the several thousand research studies published in the field of AD, only a tiny fraction are devoted to sex differences. The emergence of biomarker tests, such as CSF, brain volumetric MRI, and amyloid and tau PET scans, has allowed for a more unbiased investigation of how gender affects pathology and neuronal loss at both preclinical and clinical stages of the disease. Selected studies indicative of gender differences in atrophy, pathology, longitudinal cognitive changes, and diagnostic progression in AD are summarized below.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
